Advanced Pharma Inc. is recalling 560 bags of Hydromorphone 20 mg/100 mL (generic Dilaudid) injectable solution because the medication is sub-potent, meaning it contains less active ingredient than specified. This compounded drug was distributed in 100 mL sterile single-use bags through Avella of Houston. Because the medication is weaker than expected, patients may not receive the necessary level of pain relief, which could lead to inadequate treatment of severe pain.
The drug is sub-potent and fails to meet strength specifications, which can result in under-dosing. For patients requiring significant pain management, this lack of efficacy can lead to untreated pain and potential clinical complications.
Contact healthcare provider and return product
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.